检索结果 - Vered Stearns

Refine Results
  1. 1
    Pharmacogenomics of breast cancer therapy: An update

    Pharmacogenomics of breast cancer therapy: An update 由 Kelly Westbrook, Vered Stearns

    出版 2013
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  2. 2
    Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management

    Aromatase inhibitor-associated bone and musculoskeletal effects: new evidence defining etiology and strategies for management 由 Stéphanie Gaillard, Vered Stearns

    出版 2011
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  3. 3
    Epigenetics as a Therapeutic Target in Breast Cancer

    Epigenetics as a Therapeutic Target in Breast Cancer 由 Roisín M. Connolly, Vered Stearns

    出版 2012
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  4. 4
    Epigenetic Regulation in Estrogen Receptor Positive Breast Cancer—Role in Treatment Response

    Epigenetic Regulation in Estrogen Receptor Positive Breast Cancer—Role in Treatment Response 由 Thushangi N. Pathiraja, Vered Stearns, Steffi Oesterreich

    出版 2010
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  5. 5
    Prognostic factors in breast cancer: current and new predictors of metastasis.

    Prognostic factors in breast cancer: current and new predictors of metastasis. 由 Daniel F. Hayes, Claudine Isaacs, Vered Stearns

    出版 2001
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  6. 6
    Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Focused Update Guideline Summary

    Use of Biomarkers to Guide Decisions on Adjuvant Systemic Therapy for Women With Early-Stage Invasive Breast Cancer: American Society of Clinical Oncology Clinical Practice Focused... 由 Ian E. Krop, Nofisat Ismaila, Vered Stearns

    出版 2017
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    Management of hormone receptor-positive, HER2-negative early breast cancer

    Management of hormone receptor-positive, HER2-negative early breast cancer 由 Elaine M. Walsh, Karen L. Smith, Vered Stearns

    出版 2020
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  8. 8
    Response: Re: Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis

    Response: Re: Pharmacogenomic Variation of CYP2D6 and the Choice of Optimal Adjuvant Endocrine Therapy for Postmenopausal Breast Cancer: A Modeling Analysis 由 Daniel F. Hayes, Vered Stearns, James M. Rae, David A. Flockhart

    出版 2008
    获取全文 获取全文
    Carta
    加到收藏夹
    Saved in:
  9. 9
    Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer

    Practical clinical guidelines for assessing and managing menopausal symptoms after breast cancer 由 Martha Hickey, Christobel Saunders, Ann H. Partridge, Nanette Santoro, Hadine Joffe, Vered Stearns

    出版 2008
    获取全文 获取全文
    Revisão
    加到收藏夹
    Saved in:
  10. 10
    Drug Interactions and Pharmacogenomics in the Treatment of Breast Cancer and Depression

    Drug Interactions and Pharmacogenomics in the Treatment of Breast Cancer and Depression 由 N. Lynn Henry, Vered Stearns, David A. Flockhart, Daniel F. Hayes, Michelle Riba

    出版 2008
    获取全文
    Revisão
    加到收藏夹
    Saved in:
  11. 11
    Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer

    Potent genistein derivatives as inhibitors of estrogen receptor alpha-positive breast cancer 由 Radharani Marik, Madhan Allu, Ravi Anchoori, Vered Stearns, Christopher B. Umbricht, Saeed R. Khan

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    DNA methylation-related vitamin D receptor insensitivity in breast cancer

    DNA methylation-related vitamin D receptor insensitivity in breast cancer 由 Radharani Marik, MaryJo Fackler, Edward Gabrielson, Martha A. Zeiger, Saraswati Sukumar, Vered Stearns, Christopher B. Umbricht

    出版 2010
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Randomized Trial of a Hypnosis Intervention for Treatment of Hot Flashes Among Breast Cancer Survivors

    Randomized Trial of a Hypnosis Intervention for Treatment of Hot Flashes Among Breast Cancer Survivors 由 Gary Elkins, Joel Marcus, Vered Stearns, Michelle M. Perfect, M. Hasan Rajab, Christopher Ruud, Lynne Palamara, Timothy Z. Keith

    出版 2008
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  14. 14
    New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole – Analyses from NCIC CTG MA.17

    New onset vasomotor symptoms but not musculoskeletal symptoms associate with clinical outcomes on extended adjuvant letrozole – Analyses from NCIC CTG MA.17 由 Pedro Emanuel Rubini Liedke, Dongsheng Tu, Lois E. Shepherd, Yanin Chávarri-Guerra, Kathleen I. Pritchard, Vered Stearns, Paul E. Goss

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  15. 15
    A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors

    A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil®) in controlling hot flashes in breast cancer survivors 由 Vered Stearns, Claudine Isaacs, Julia H. Rowland, Jeffrey Crawford, M.J. Ellis, Rita Kramer, W. Lawrence, John Hanfelt, Daniel F. Hayes

    出版 2000
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  16. 16
    A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma

    A Clinicopathologic Analysis of 45 Patients With Metaplastic Breast Carcinoma 由 Ashley Cimino‐Mathews, Sangita Verma, Maria Cristina Figueroa Magalhães, Stacie C. Jeter, Zhe Zhang, Pedram Argani, Vered Stearns, Roisín M. Connolly

    出版 2016
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  17. 17
    Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors

    Conducting a Virtual Clinical Trial in HER2-Negative Breast Cancer Using a Quantitative Systems Pharmacology Model With an Epigenetic Modulator and Immune Checkpoint Inhibitors 由 Hanwen Wang, Richard J. Sové, Mohammad Jafarnejad, Sondra Rahmeh, Elizabeth M. Jaffee, Vered Stearns, Evanthia T. Roussos Torres, Roisín M. Connolly, Aleksander S. Popel

    出版 2020
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  18. 18
    CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients

    CYP2D6 and UGT2B7 Genotype and Risk of Recurrence in Tamoxifen-Treated Breast Cancer Patients 由 James M. Rae, S. Drury, Daniel F. Hayes, Vered Stearns, Jacklyn N. Thibert, Ben P. Haynes, Janine Salter, Ivana Šestak, Jack Cuzick, Mitch Dowsett

    出版 2012
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  19. 19
    Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine

    Active Tamoxifen Metabolite Plasma Concentrations After Coadministration of Tamoxifen and the Selective Serotonin Reuptake Inhibitor Paroxetine 由 Vered Stearns, Michael D. Johnson, James M. Rae, A. M. Morocho, Antonella Novielli, Pankaj Bhargava, Daniel F. Hayes, Zeruesenay Desta, David A. Flockhart

    出版 2003
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  20. 20
    Monitoring of neoadjuvant chemotherapy using multiparametric, 23Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer

    Monitoring of neoadjuvant chemotherapy using multiparametric, 23Na sodium MR, and multimodality (PET/CT/MRI) imaging in locally advanced breast cancer 由 Michael A. Jacobs, Ronald Ouwerkerk, Antonio C. Wolff, Edward Gabrielson, Hind Nassar Warzecha, Stacie C. Jeter, David A. Bluemke, Richard L. Wahl, Vered Stearns

    出版 2011
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: